Browsing Category
LIFE SCIENCES
Prelude Therapeutics Files for Its IPO
Prelude Therapeutics Incorporated files for its IPO. According to the S-1 filing, the IPO will see the company…
Symrise AG to Acquire Sensient Technologies
On Monday Nov. 23, Symrise AG's (SYIEY) fragrance business announced that it has entered into a definitive…
Frazier Lifesciences Acquisition Corporation IPO
Frazier Lifesciences Acquisition Corporation has recently filed paperwork with the SEC as part of its IPO…
The Recent Evolution of Biotechnology
There is no doubt we’re observing immense progress in the macroscopic biomedical biotechnology sciences.…
Talaris Therapeutics, Inc. Funds Closed $115 Million
Talaris Therapeutics, Inc. is under the spotlight for raising funds. It isn’t the first time a company has…
Investing in Life Sciences – a Year of Growth
Since 2019, experts believe that the time is ripe for gathering benefits from early-stage life sciences…
LAVA Therapeutics Advances Novel Immuno-oncology Programs by Raising $83…
LAVA Therapeutics has announced that it will invest $83 million as series C financing for advancing novel…
UPMC Appoints Life Sciences Expert: Cunicelli as President of UPMC…
The venture capital arm of UPMC is going to see some impactful changes in January 2021. After the whirlwind…
A New Era of Tumor Detection
Cancer is a common enemy, and tumor detection is at the medical forefront. Every year, over 600,000 people…
Powerful Trials for Brain Cancer Treatment – Efforts of Quadriga…
Quadriga BioSciences, Inc. has developed a reputation for developing cancer therapies. These therapies’…